Author

Jie Wang

Roswell Park Comprehensive Cancer CenterORCID 0000-0002-3432-8085Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Jie Wang17 papers · Changzhi Medical College

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Bo XuiD· 1 shared David W. GoodrichiD· 1 shared Eduardo Cortes GomeziD· 1 shared Henry W. LongiD· 1 shared Jianmin WangiD· 1 shared Justine J. JacobiiD· 1 shared Kristine M. WadoskyiD· 1 shared Neha JaiswaliD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Bo XuORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

EZH2 alters aggressive variant prostate cancer subtype evolution, but is not required for neuroendocrine prostate cancer

Justine J. Jacobi, Kristine M. Wadosky, Neha Jaiswal, Xiaojing Zhang, Yanqing Wang, Prashant K. Singh, Jie Wang, Eduardo Cortes Gomez, Jianmin Wang, Bo Xu, Paloma Cejas, Shweta Kukreja, Henry W. Long, David W. Goodrich

This study shows that EZH2 influences the evolution of aggressive prostate cancer subtypes but is not essential for neuroendocrine prostate cancer development.

bioRxiv · May 13, 2025 · PreprintCancer Biology